These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 16414404)

  • 41. Microembolism during foam sclerotherapy of varicose veins.
    Ceulen RP; Sommer A; Vernooy K
    N Engl J Med; 2008 Apr; 358(14):1525-6. PubMed ID: 18385510
    [No Abstract]   [Full Text] [Related]  

  • 42. Should foam made with physiologic gases be the standard in sclerotherapy?
    Wong M
    Phlebology; 2015 Oct; 30(9):580-6. PubMed ID: 25392457
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Three cases of stroke following peripheral venous interventions.
    Ma RW; Pilotelle A; Paraskevas P; Parsi K
    Phlebology; 2011 Oct; 26(7):280-4. PubMed ID: 21422195
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute Ischemic Stroke in a Young Woman With No Known Risk Factors.
    Abdelhamid N; Farooq S; Sarraj A
    WMJ; 2018 Mar; 117(1):42-44. PubMed ID: 29677415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 1064 nm Nd:YAG long pulse laser after polidocanol microfoam injection dramatically improves the result of leg vein treatment: a randomized controlled trial on 517 legs with a three-year follow-up.
    Moreno-Moraga J; Smarandache A; Pascu ML; Royo J; Trelles MA
    Phlebology; 2014 Dec; 29(10):658-66. PubMed ID: 23989971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sclerotherapy in an undetected pregnancy - a catastrophe?
    Reich-Schupke S; Leiste A; Moritz R; Altmeyer P; Stücker M
    Vasa; 2012 Jul; 41(4):243-7. PubMed ID: 22825857
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical significance of cerebrovascular gas emboli during polidocanol endovenous ultra-low nitrogen microfoam ablation and correlation with magnetic resonance imaging in patients with right-to-left shunt.
    Regan JD; Gibson KD; Rush JE; Shortell CK; Hirsch SA; Wright DD
    J Vasc Surg; 2011 Jan; 53(1):131-7. PubMed ID: 20864303
    [TBL] [Abstract][Full Text] [Related]  

  • 48. What is the current role of foam sclerotherapy in treating reflux and varicosities?
    Wright DD
    Semin Vasc Surg; 2010 Jun; 23(2):123-6. PubMed ID: 20685568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Delayed Nicolau's livedoid dermatitis after ultrasound-guided sclerotherapy.
    Ramelet AA; Parmentier L
    Dermatol Surg; 2010; 36(1):155-8. PubMed ID: 19889155
    [No Abstract]   [Full Text] [Related]  

  • 50. Iatrogenic gas embolism after foam sclerotherapy?
    Bessereau J; Coulange M; Boussuges A; Chenaitia H; Michelet P
    Ann Fr Anesth Reanim; 2011 Sep; 30(9):e31. PubMed ID: 21764544
    [No Abstract]   [Full Text] [Related]  

  • 51. Polidocanol concentration and time affect the properties of foam used for sclerotherapy.
    VAN Deurzen B; Ceulen RP; Tellings SS; VAN DER Geld C; Nijsten T
    Dermatol Surg; 2011 Oct; 37(10):1448-55. PubMed ID: 21790848
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sclerotherapy of varicose leg veins. Technique, indications and complications.
    Kern P
    Int Angiol; 2002 Jun; 21(2 Suppl 1):40-5. PubMed ID: 12515979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Middle cerebral air embolism after foam sclerotherapy.
    Asbjornsen CB; Rogers CD; Russell BL
    Phlebology; 2012 Dec; 27(8):430-3. PubMed ID: 22368193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Review of published information on foam sclerotherapy.
    Stücker M; Kobus S; Altmeyer P; Reich-Schupke S
    Dermatol Surg; 2010 Jun; 36 Suppl 2():983-92. PubMed ID: 20590705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Subcutaneous injection of liquid and foamed polidocanol: extravasation is not responsible for skin necrosis during reticular and spider vein sclerotherapy.
    Schuller-Petrović S; Pavlović MD; Neuhold N; Brunner F; Wölkart G
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):983-6. PubMed ID: 21740464
    [TBL] [Abstract][Full Text] [Related]  

  • 56. European guidelines for sclerotherapy in chronic venous disorders.
    Rabe E; Breu FX; Cavezzi A; Coleridge Smith P; Frullini A; Gillet JL; Guex JJ; Hamel-Desnos C; Kern P; Partsch B; Ramelet AA; Tessari L; Pannier F;
    Phlebology; 2014 Jul; 29(6):338-54. PubMed ID: 23559590
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of polidocanol foam administration into rat peripheral veins on pulmonary parenchyma.
    de Moraes Silva MA; Ferreira RG; de Jesus-Silva SG; Cardoso RS; Miranda F
    Phlebology; 2018 Mar; 33(2):122-127. PubMed ID: 28092205
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polidocanol foam sclerotherapy of persisting postoperative seromas after varicose vein surgery: a series of six cases.
    Moritz RK; Reich-Schupke S; Altmeyer P; Stücker M
    Phlebology; 2013 Oct; 28(7):341-6. PubMed ID: 22865419
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in venous function after foam sclerotherapy of varicose veins.
    Brunken A; Rabe E; Pannier F
    Phlebology; 2009 Aug; 24(4):145-50. PubMed ID: 19620696
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Foam sclerotherapy: investigating the need for sterile air.
    de Roos KP; Groen L; Leenders AC
    Dermatol Surg; 2011 Aug; 37(8):1119-24. PubMed ID: 21615606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.